April 1, 2025
Update: Nordic Capital-backed GesundHeits Deutschland (“GHD”) is in a Harris Williams-guided sales process to divest its Sangro Medical Service business amid debt issues, generating 2024 revenues of EUR 350m and EBITDA of EUR 30m, acc. to sources (NKP | M&A Insights Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights